SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $47,000 | -43.4% | 39,743 | +56.6% | 0.00% | – |
| Q4 2021 | $83,000 | -17.8% | 25,386 | +12.0% | 0.00% | – |
| Q3 2021 | $101,000 | -18.5% | 22,675 | 0.0% | 0.00% | – |
| Q2 2021 | $124,000 | -17.9% | 22,675 | +12.6% | 0.00% | – |
| Q1 2021 | $151,000 | -27.4% | 20,133 | +5.1% | 0.00% | – |
| Q4 2020 | $208,000 | +58.8% | 19,150 | +29.7% | 0.00% | – |
| Q3 2020 | $131,000 | -16.6% | 14,766 | 0.0% | 0.00% | – |
| Q2 2020 | $157,000 | +42.7% | 14,766 | -20.6% | 0.00% | – |
| Q1 2020 | $110,000 | -14.1% | 18,594 | 0.0% | 0.00% | – |
| Q4 2019 | $128,000 | -9.2% | 18,594 | +36.7% | 0.00% | – |
| Q3 2019 | $141,000 | +11.9% | 13,602 | 0.0% | 0.00% | – |
| Q2 2019 | $126,000 | +32.6% | 13,602 | +31.2% | 0.00% | – |
| Q1 2019 | $95,000 | – | 10,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |